Towards Healthcare
GCC Compounding Pharmacy Market Size Hits USD 40.26 Bn by 2034

GCC Compounding Pharmacy Market Report 2025 Future Growth Driven by AI, Oncology and Pediatric Compounding

Based on market forecasts, the global GCC compounding pharmacy market, projected at USD 16.39 million in 2024, is expected to reach USD 40.26 million by 2034, growing at a CAGR of 9.27% over the forecast period.The growing demand for personalized medicines and technological advancements is the major growth factor of the market. Saudi Arabia led the market owing to favorable government policies and the increasing number of compounding pharmacies.

  • Insight Code: 5898
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The GCC compounding pharmacy market is projected to reach USD 40.26 million by 2034, growing at a CAGR of 9.27% from 2025 to 2034.

Saudi Arabia is leading the GCC compounding pharmacy market due to favorable government policies, an increasing number of compounding pharmacies, and rising awareness

The GCC compounding pharmacy market includes four segments including by compounding type, by therapy area, by end-user, and by country.

Key trends include the growing demand for personalized medicines, technological advancements in drug dispensing, and favorable regulatory support.

International Agency for Research on Cancer, Gulf Times, Vision2030.gov.sa